|
1
|
Abraham WT, Stevenson LW, Bourge RC,
Lindenfeld JA, Bauman JG and Adamson PB: CHAMPION Trial Study
Group: Sustained efficacy of pulmonary artery pressure to guide
adjustment of chronic heart failure therapy: Complete follow-up
results from the CHAMPION randomised trial. Lancet. 387:453–461.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sharma A, Lavie CJ, Borer JS, Vallakati A,
Goel S, Lopez-Jimenez F, Arbab-Zadeh A, Mukherjee D and Lazar JM:
Meta-analysis of the relation of body mass index to all-cause and
cardiovascular mortality and hospitalization in patients with
chronic heart failure. Am J Cardiol. 115:1428–1434. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
JianXin C, Xue X, ZhongFeng L, Kuo G,
FeiLong Z, ZhiHong L, Xian W and HongCai S: Qishen Yiqi Drop Pill
improves cardiac function after myocardial ischemia. Sci Rep.
6:243832016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Satake H, Fukuda K, Sakata Y, Miyata S,
Nakano M, Kondo M, Hasebe Y, Segawa M and Shimokawa H: CHART-2
Investigators: Current status of primary prevention of sudden
cardiac death with implantable cardioverter defibrillator in
patients with chronic heart failure - A report from the CHART-2
Study. Circ J. 79:381–390. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Troughton RW, Frampton CM, Brunner-La
Rocca HP, Pfisterer M, Eurlings LW, Erntell H, Persson H, O'Connor
CM, Moertl D, Karlström P, et al: Effect of B-type natriuretic
peptide-guided treatment of chronic heart failure on total
mortality and hospitalization: An individual patient meta-analysis.
Eur Heart J. 35:1559–1567. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gaggin HK, Szymonifka J, Bhardwaj A,
Belcher A, De Berardinis B, Motiwala S, Wang TJ and Januzzi JL Jr:
Head-to-head comparison of serial soluble ST2, growth
differentiation factor-15, and highly-sensitive troponin T
measurements in patients with chronic heart failure. JACC Heart
Fail. 2:65–72. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Arzt M, Woehrle H, Oldenburg O, Graml A,
Suling A, Erdmann E, Teschler H and Wegscheider K: SchlaHF
Investigators: prevalence and predictors of sleep-disordered
breathing in patients with stable chronic heart failure: The
SchlaHF Registry. JACC Heart Fail. 4:116–125. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yang Q and Cao Y: Study on mechanisms and
myocardial protective effect of Qishen Yiqi dropping pills on rats
with myocardial infarction. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue.
29:501–505. 2017.(In Chinese). PubMed/NCBI
|
|
9
|
Yu FC, Xu YJ, Tong JY, Lu ZZ and Zhang XH:
Therapeutic effects of Qishen Yiqi Dropping Pill on myocardial
injury induced by chronic hypoxia in rats. Chin J Nat Med.
13:776–780. 2015.PubMed/NCBI
|
|
10
|
Cui ZT, Wei WL, Liu M and Wang WJ: Effect
of pretreatment with qishen yiqi dropping pills on right cardiac
function of patients undergoing valve replacement. Zhongguo Zhong
Yao Za Zhi. 39:916–919. 2014.(In Chinese). PubMed/NCBI
|
|
11
|
Liu W, Gao FF, Li Q, Lv JW, Wang Y, Hu PC,
Xiang QM and Wei L: Protective effect of astragalus polysaccharides
on liver injury induced by several different chemotherapeutics in
mice. Asian Pac J Cancer Prev. 15:10413–10420. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang J, Lu L, Wang Y, Wu Y, Han J, Wang W,
Li C and Tu P: Qishenyiqi Dropping Pill attenuates myocardial
fibrosis in rats by inhibiting RAAS-mediated arachidonic acid
inflammation. J Ethnopharmacol. 176:375–384. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang Y, Wang Q, Li C, Lu L, Zhang Q, Zhu R
and Wang W: A review of Chinese herbal medicine for the treatment
of chronic heart failure. Curr Pharm Des. 23:5115–5124.
2017.PubMed/NCBI
|
|
14
|
Zhao M, Zheng S, Yang J, Wu Y, Ren Y, Kong
X, Li W and Xuan J: Suppression of TGF-β1/Smad signaling pathway by
sesamin contributes to the attenuation of myocardial fibrosis in
spontaneously hypertensive rats. PLoS One. 10:e01213122015.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li S, Fan Q, He S, Tang T, Liao Y and Xie
J: MicroRNA-21 negatively regulates Treg cells through a
TGF-β1/Smad-independent pathway in patients with coronary heart
disease. Cell Physiol Biochem. 37:866–878. 2015. View Article : Google Scholar : PubMed/NCBI
|
